Acceleration Initiative

An Outcome Driven Approach

Our Acceleration Initiative projects are highly innovative, address a significant challenge in pediatric cancer drug development, and have a strong probability of clinical application — ready to reach patients within three to five years. To learn more about the grant application process, click here.

ACCELERATION INITIATIVE – ACTIVE PROJECTS

Gregory Friedman, MD
University of Alabama at Birmingham
Focus: Pediatric High-Grade Glioma
Project title: Overcoming the Adverse Microenvironment of Pediatric High-Grade Gliomas

David Langenau, PhD
Massachusetts General Hospital
Focus: Rhabdomyosarcoma
Project Title:Targeting p53 in childhood rhabdomyosarcoma

Dr. Andrei Thomas-Tikhonenko – The Children’s Hospital of Philadelphia

Andrei Thomas-Tikhonenko, PhD
Children’s Hospital of Philadelphia
Focus: High-risk Pediatric Cancers – Neuroblastoma and Diffuse Midline Glioma
Project title: Targeting splicing-derived neo-epitopes in high-risk pediatric cancers

Frequently Asked Questions

When does the application window open to submit Letters of Intent (LOIs)?

CureSearch Grant Cycle Timeline

RFAs are posted in ProposalCentral annually, according to the below timeline.

TIMELINE	DATES
Request for Applications Opens	Early June
Letter of Intent Deadline	Mid-June
LOI Notification/Full Applications Invited	Early September
Full Applications Due	Mid-October
Earliest Award Notification*	Early January